<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-123960</identifier>
<setSpec>1889-7347</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Assessment of the excessive protein expression in patients with minor AHSS</dc:title>
<dc:description xml:lang="en">Introduction: The apnea-hypopnea sleep syndrome (AHSS) is a frequent illness, associated to morbidity and mortality in its most serious stages. It has been postulated that AHSS may have a differential protein expression with regards to a group of patients without AHSS. A study has been designed to determine whether or not a proteomic study is able to identify the overly expressed proteins in patients with minor AHSS. Method: Full clinical background was noted for the subjects, as well as physical examination, general biochemical tests, diagnostic polysomnography and proteomic study using iTRAQ (isobaric tags for relative and absolute quantification). Included in the study were 11 patients with AHSS, an apnea-hypopnea index (AHI) &amp;#8805; 5, whose results were compared to a control group without AHSS (AHI &lt; 5). Those with SapO2 &amp;#8804; 93% and serious organ disease were excluded. Results: the patients presented an apnea-hypoapnea index of 12 ± 3 and an average age of 44 ± 7 years. In AHSS, 3 overly expressed proteins were observed (ratio &gt; 1.3) with regards to the control group. These proteins were PRO0684 (gi-6855601), short immunoglobulin lambda chain VLJ (gi-21669561) and the kininogen HMW precursor (gi-68785). The main functions and biological processes include inflammation, immune response and coagulation. Conclusions: With regards to the control group, patients with AHSS showed overly expressed proteins. These proteins may be helpful in the diagnosis or in increasing knowledge about underlying physical-pathological processes. Nevertheless, this data is preliminary, with scope of which must establish future studies (AU)</dc:description>
<dc:creator>Arenas Delarriva, M. S</dc:creator>
<dc:creator>García Porcuna, I</dc:creator>
<dc:creator>Jurado Gámez, B</dc:creator>
<dc:creator>Bujalance Cabrera, C</dc:creator>
<dc:creator>Muñoz Cabrera, L</dc:creator>
<dc:creator>Feu Collado, N</dc:creator>
<dc:creator>Caballero Ballesteros, L</dc:creator>
<dc:creator>Muñoz Calero, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: El síndrome de apneas-hipopneas del sueño (SAHS) es una enfermedad frecuente y asociada a morbimortalidad en estadios graves. Se postula que el SAHS puede tener una expresión proteíca diferencial respecto a un grupo de pacientes sin SAHS. Se diseña un trabajo para determinar si un estudio proteómico es capaz de identificar proteínas sobreexpresadas en enfermos con SAHS leve. Métodos: A los sujetos se les realizó una historia clínica, exploración física, bioquímica general, polisomnografía diagnóstica y estudio proteómico mediante iTRAQ (isobaric tags for relative and absolute quantification). Se incluyeron 11 pacientes con SAHS, índice de apneas-hipopneas (IAH) &amp;#8805; 5, cuyos resultados fueron comparados con un grupo sin SAHS (IAH &lt; 5). Fueron excluidos aquellos con SapO2 &amp;#8804; 93% y enfermedad grave de órgano. Resultados: los pacientes presentaron un índice de apneashipopneas de 12 ± 3 y una edad media de 44 ± 7 años. En el SAHS se observaron 3 proteínas sobreexpresadas (ratio &gt; 1.3) respecto al grupo control. Estas proteínas fueron la PRO0684 (gi-6855601), la immunoglobulina lambda de cadena corta VLJ (gi-21669561) y el kininogeno HMW precursor (gi-68785). Las principales funciones y procesos biológicos en los que están involucrados son la inflamación, respuesta inmune y coagulación. Conclusiones: Respecto a un grupo control, en los pacientes con SAHS se observan proteínas sobreexpresadas. Estas proteínas pueden ser de ayuda para el diagnóstico o para aumentar el conocimiento en procesos fisiopatológicos subyacentes. No obstante, son datos preliminares, cuyo alcance debe establecerse en estudios posteriores (AU)</dc:description>
<dc:source>Rev. esp. patol. torac;24(2): 178-183, abr.-jun. 2012. tab, ilus</dc:source>
<dc:identifier>ibc-123960</dc:identifier>
<dc:title xml:lang="es">Valoración de la sobreexpresión proteica en pacientes con SAHS leve</dc:title>
<dc:subject>^d331</dc:subject>
<dc:subject>^d34202^s22011</dc:subject>
<dc:subject>^d34202^s22044</dc:subject>
<dc:subject>^d34202</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11932</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d37630</dc:subject>
<dc:type>article</dc:type>
<dc:date>201206</dc:date>
</metadata>
</record>
</ibecs-document>
